National Research Stock Forecast, Price & News

National Research (NASDAQ:NRC) Frequently Asked Questions

How has National Research's stock price been impacted by Coronavirus (COVID-19)?

National Research's stock was trading at $52.18 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NRC stock has decreased by 23.2% and is now trading at $40.05.
View which stocks have been most impacted by COVID-19.

When is National Research's next earnings date?

National Research is scheduled to release its next quarterly earnings announcement on Tuesday, February 8th 2022.
View our earnings forecast for National Research.

How were National Research's earnings last quarter?

National Research Co. (NASDAQ:NRC) released its earnings results on Tuesday, November, 2nd. The company reported $0.38 EPS for the quarter. The business earned $37.77 million during the quarter. National Research had a net margin of 24.96% and a trailing twelve-month return on equity of 48.54%.
View National Research's earnings history.

How often does National Research pay dividends? What is the dividend yield for National Research?

National Research announced a quarterly dividend on Friday, November 19th. Shareholders of record on Thursday, December 30th will be paid a dividend of $0.12 per share on Friday, January 14th. This represents a $0.48 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend is Wednesday, December 29th.
View National Research's dividend history.

Is National Research a good dividend stock?

National Research pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.18%. National Research does not yet have a strong track record of dividend growth. The dividend payout ratio of National Research is 34.04%. This payout ratio is at a healthy, sustainable level, below 75%.
View National Research's dividend history.

Who are National Research's key executives?

National Research's management team includes the following people:

• Michael D. Hays, President, Chief Executive Officer & Director
• Jona S. Raasch, Chief Operating Officer
• Kevin R. Karas, CFO, Secretary, Treasurer & Senior Vice President
• Helen L Hrdy, Chief Growth Officer

What is Michael D. Hays' approval rating as National Research's CEO?

85 employees have rated National Research CEO Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among National Research's employees.

Who are some of National Research's key competitors?

Some companies that are related to National Research include SomaLogic (SLGC), Anavex Life Sciences (AVXL), Absci (ABSI), Zymergen (ZY), Inotiv (NOTV), Starpharma (SPHRY), Luna Innovations (LUNA), Auxly Cannabis Group (CBWTF), iSpecimen (ISPC), Science 37 (SNCE), Bioqual (BIOQ), AIkido Pharma (AIKI), AIkido Pharma (AIKI), Eloxx Pharmaceuticals (ELOX) and HedgePath Pharmaceuticals (HPPI).
View all of NRC's competitors.

What other stocks do shareholders of National Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD).

What is National Research's stock symbol?

National Research trades on the NASDAQ under the ticker symbol "NRC."

Who are National Research's major shareholders?

National Research's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (13.12%), Neuberger Berman Group LLC (3.82%), BlackRock Inc. (3.52%), Conestoga Capital Advisors LLC (2.57%), Dimensional Fund Advisors LP (2.53%) and Renaissance Technologies LLC (1.74%). Company insiders that own National Research stock include Amandla Mk Trust, Joann M Martin, John N Nunnelly, Kevin R Karas and Steven D Jackson.
View institutional ownership trends for National Research.

Which major investors are selling National Research stock?

NRC stock was sold by a variety of institutional investors in the last quarter, including Royal Bank of Canada, Conestoga Capital Advisors LLC, BlackRock Inc., Neuberger Berman Group LLC, Renaissance Technologies LLC, Janus Henderson Group PLC, US Bancorp DE, and Morgan Stanley. Company insiders that have sold National Research company stock in the last year include Amandla Mk Trust, and Joann M Martin.
View insider buying and selling activity for National Research or view top insider-selling stocks.

Which major investors are buying National Research stock?

NRC stock was purchased by a variety of institutional investors in the last quarter, including Mawer Investment Management Ltd., Martingale Asset Management L P, Daiwa Securities Group Inc., Willis Investment Counsel, Seizert Capital Partners LLC, Kayne Anderson Rudnick Investment Management LLC, SG Americas Securities LLC, and Barclays PLC.
View insider buying and selling activity for National Research or or view top insider-buying stocks.

How do I buy shares of National Research?

Shares of NRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Research's stock price today?

One share of NRC stock can currently be purchased for approximately $40.05.

How much money does National Research make?

National Research has a market capitalization of $1.02 billion and generates $133.28 million in revenue each year. The company earns $37.26 million in net income (profit) each year or $1.41 on an earnings per share basis.

How many employees does National Research have?

National Research employs 485 workers across the globe.

What is National Research's official website?

The official website for National Research is www.nrchealth.com.

Where are National Research's headquarters?

National Research is headquartered at 1245 Q STREET, LINCOLN NE, 68508.

How can I contact National Research?

National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The company can be reached via phone at (402) 475-2525 or via fax at 402-475-9061.